This article presents the results of the geoarchaeological study of earthen building materials used in a Tartessic public building at Casas del Turuñuelo. The construction dates back to the fifth century BCE and is one of the monumental buildings of Tartessic culture, characterized by its complex architecture, prestige goods, and intentional destruction after a feast and animal sacrifice. We applied an integrated methodology combining macro and micro approaches to investigate earthen construction processes, such as techniques, labour organization, workers' specialization, and environmental exploitation.
View Article and Find Full Text PDFZooarchaeological analyses of the skeletal remains of 52 animals unearthed in the courtyard of an Iron Age Tartessian building known as Casas del Turuñuelo (Badajoz, Spain) shed light on a massive sacrifice forming part of a series of rituals linked to the site's last period of activity and final abandonment. The rites took place towards the end of the 5th century BCE when both the building (intentionally destroyed) and the sacrificed animals were intentionally buried under a tumulus 90 m in diameter and 6 m high. The main objective of the zooarchaeological and microstratigraphic analyses was to determine the phasing of the sacrificial depositions.
View Article and Find Full Text PDFObjectives: To assess the efficacy of long-term treatment with nebulized colistin in reducing the number of respiratory infections, emergency consultations and hospitalizations in oncological patients.
Methods: A retrospective, observational, single-centre study including patients with solid or haematologic malignancies, or pulmonary GVHD after HSTC who received treatment with nebulized colistin for at least six-months to prevent recurrent respiratory infections (July 2010 to June 2017).
Results: Twelve patients were included (median age: 54.
A large number of COPD patients are smokers. The particular characteristics of this group as well as their need to quit usually require psychological counselling and pharmacological treatment to achieve abstinence and, often, intensively. Little information is available about this issue.
View Article and Find Full Text PDFBackground Aims: Cytotherapy is a promising option for neurodegenerative disease treatment. Because of the fatal prognosis and imperative need for effective treatment, amyotrophic lateral sclerosis (ALS) patients request this therapy before its effectiveness has been verified. The increase in clinics offering cytotherapies but providing little scientific information has prompted considerable medical tourism.
View Article and Find Full Text PDF